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Introduction 
Presently, there is an increasingly amount of research effort focused on determining the 
prevalence and impact of drug driving on public roads.  A considerable body of literature is 
accumulating that has focused on detecting the presence of drugs in body fluids of those 
who have been involved in a crash (de Rio, Gomez, Sancho & Alvarez, 2002; Drummer et 
al., 2003).   
However, currently questions remain regarding the prevalence of individuals who engage in 
drug driving practices that have yet to be apprehended or involved in a crash.  The main 
avenue for obtaining such information has been through self-report data provided by 
motorists, which has indicated that the self-reported prevalence of drug driving varies 
markedly between 2% and 90% of respondents, although most research suggests between 
3% and 10% (Kelly, Darke & Ross, 2004).  This variation is dependent upon whether 
respondents have been referring to drug driving in general or to a specific substance.  
Despite this, research is generally indicating that the most common drugs combined with 
driving are usually cannabis (Davey, Leal & Freeman, 2007; Drummer et al., 2003), and 
less commonly amphetamines and heroin (Davey et al., 2007), although it is noted that a 
limitation of this body of research is that such studies have predominantly consisted of 
cannabis users.   
 
In contrast, research studies that have included the collection of bodily fluids have 
predominantly involved drivers who are already suspected of driving under the influence of 
alcohol and/or drugs.  Currently, a number of drug testing trials are underway in different 
countries, however little published research exists regarding the output of these studies or 
the strengths and limitations of the research method.  As a result, the aims of this study 
were to: (a) measure the prevalence of drug driving among a sample of Queensland drivers, 
and (b) investigate the self-reported frequency of general motorists’ involvement in drug 
driving behaviour. 
Method 
Drivers stopped at Random Breath Testing operations in three locations in Queensland 
(e.g., one regional, rural and metropolitan) were approached and asked by operational 
police to participate in the drug driving research, which was positioned on average 50 
metres further down the road. Participation was voluntary and involved completing a self-
report questionnaire regarding recent illicit drug use and drug driving in the previous 12 
months, and providing a sample of oral fluid that could later be screened for the presence of 
drugs. The roadside procedure took approximately 5-20 minutes to complete and drivers 
received a one-off payment of $20 cash to reimburse them for their time.  Data were 
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collected over a two month period, on ten separate occasions, usually between the hours of 
5pm and 1am1.   
 
A 12 item self-report questionnaire was designed to assess a variety of demographic data 
(e.g., gender, age, years driving) as well as self-reported drug use and the frequency of drug 
driving behaviour.  Participants responded to questions that investigated the most recent use 
of marijuana / cannabis (within four hours, within the last 24 hours, within the last week, 
within the last month, within the last year, more than a year ago, have never used). This 
question was repeated for meth / amphetamine type substances (such as speed, oil, base, 
crystal), heroin and cocaine. Participants were also required to indicate how often in the 
previous 12 months they had operated a motor vehicle (including a motorcycle) within four 
hours of using marijuana / cannabis (every day, more than once a week, about once a week, 
11 – 20 times, 3 – 10 times, once or twice, never). Once again, this question was repeated 
for meth / amphetamine type substances (such as speed, oil, base, crystal), heroin and 
cocaine.  
 
In addition, oral fluid samples were collected, stored and screened off-site at a later date 
using the Cozart® RapiScan or DDS oral fluid drug test device.  The RapiScan device was 
originally used for approximately the first 600 collections and was then replaced by the 
newly released DDS device.  The arrival and adoption of the DDS device allowed the 
roadside intercept time to markedly decrease. The DDS collection system decreased the 
collection time for approximately 10 – 20 minutes to less than one minute.  The research 
team deemed that there were no methodological/analytical problems in upgrading the 
collection system during the research.  
 
Using the screening device samples were screened for a number of drugs including 
cannabis (THC), cocaine, amphetamine, methamphetamine / MDMA.  Opiates were also 
screened, however they are not reported in this paper, as codeine is found in both over the 
counter and prescription medications in Australia.    
 
Results 
Sample and Response Rate 
A total of 2657 motorists participated in the studies which were conducted over three 
regions: (i) Brisbane n = 1587, (ii) Townsville n = 794 & (iii) Gold Coast n = 276.  Due to 
resourcing constraints and the referral process from the Police RBT site, it was not possible 
to obtain an accurate measurement of the response rate over the entire data collection 
period2. However, on one occasion the response rate was assessed across two sites during a 
shift where an additional researcher counted the number of drivers approached to 
participate and noted their response. Drivers of 63 cars from a total of 85 participated in the 
project, resulting in a response rate of 74.12%.  
 
More than half the participants were male (n = 1670, 63.5%), aged between 16 and 66 years 
(mean age = 28.74 years, SD = 11.57).  On average, participants had been driving for 11.04 
                                                 
1 Workplace health and safety requirements resulted in the current roadside project only being 
implemented with the presence of the Queensland Police Service.  RBT operations were deemed to be 
the most compatible roadside activity and thus drug testing procedures corresponded within traditional 
RBT operational hours e.g., 5pm – 1am.   
2 The procedure usually consisted of RBT operational police officers informing motorists (who had 
given a breath sample) that they had the opportunity to participate in an anonymous research drug 
driving project being conducted approximately 100 metres down the road.   
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years (SD = 11.57).  Most reported driving daily (n = 2181, 82.9%) or three to five times 
per week (n = 385, 14.5%).  
 
Prevalence of Positive Drug Tests 
Screening analysis revealed that oral fluid samples from 101 drivers (3.80% of the total 
sample) contained at least one illicit substance.  A comparison was undertaken between the 
drink driving and drug driving detection rates for the Townsville area which revealed that 
drug driving detection rates was more prevalent (4.91%) than drink driving (0.8%3).  Table 
1 outlines the results by drug group detected in the three regions. As depicted in Table 1, 
the most common drug detected was the methylamphetamine/MDMA group (53 cases), 
followed by delta 9 THC (46 cases), amphetamines (23 cases) and cocaine (4 cases).   
There were relatively minimal proportional differences identified in drug frequency 
between the regions, although it is noted that detection rates for 
methylamphetamine/MDMA were highest in Brisbane, while delta 9 THC was most 
commonly detected in Townsville.  In regards to combined substances, 21 samples were 
screened as positive for 2 drugs, while 2 samples tested positive for 3 drugs.  Not 
surprisingly (due to illicit manufacturing recipes), the most common combination of drugs 
were amphetamines and methylamphetamine/MDMA (65%).  
 
Compared with the total participant pool, the 101 drivers who provided samples that were 
confirmed positive for at least one illicit substance were slightly more likely to be male 
(n = 64%), marginally younger than non-positive participants (25yrs vs 28yrs) had less 
driving experience (7.8yrs vs 11.1yrs), but they did not report a higher frequency of general 
driving. 
 
Table 1. Number and Proportion of Positive Screening Tests by Drug Group  
 Total N = 2657 
Brisbane 
N = 1587 
Townsville 
N = 794 
Gold Coast 
N = 276 
Meth/MDMA  53 (1.99%)  35 (2.20%)  16 (2.01%)  2 (.72%) 
Amphetamines   23 (.86%)  17 (1.07%)  3 (.37%)  3 (1.08%) 
Cannabis (THC)  46 (1.73%)  20 (1.26%)  20 (2.51)  6 (2.17%) 
Cocaine  4 (.15%)  2 (.12%)  2 (.25%)  0 (0.00%) 
Total Illicit Substances  126 (4.72%)  74 (4.66%)  41 (5.16%)  11 (3.98%) 
 
Self-reported Prevalence of Drug Driving 
In addition to the analysis of body fluids, an investigation was also undertaken to examine 
participants’ self-reported drug use and drug driving behaviours.  Firstly regarding drug 
use, the most commonly consumed drug was cannabis, with 23.6% reporting the use of the 
substance within the last year, and 8.3% of this group reporting usage in the last week.  In 
contrast, only 8.9% reported amphetamine use in the last year and 8.3% 
methylamphetamine/MDMA use in the last year. A point to note is that in Queensland 
                                                 
3 Relatively few individuals charged with drink driving participated in the drug driving research, and 
thus the drug and drinking drivers consisted of separate samples.   
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many illicit drug users refer to methylamphetamine as amphetamine.  Finally, 3.1% 
reported using cocaine and 0.3% of the sample reported using heroin during the last year. 
Chi-square analysis revealed males were more likely to report regular cannabis use than 
females X2 (6, N = 2657, = 46.33, p = .000), while small cell sizes precluded analysis of the 
other substances. Differences were identified between the regions on self-reported 
frequency of drug use, as participants in Townsville reported proportionally higher 
frequencies of cannabis use, while the Gold Coast and Brisbane reported higher 
amphetamine and methylamphetamine/MDMA consumption.      
 
For drug driving, similar to the above findings, the most common substance combined with 
driving was reported to be cannabis (see Table 2).  Specifically, 4.4% of the sample 
reported using cannabis before driving at least once a week, while approximately 1.0% 
reported the use of amphetamines, and less than 1.0% reporting cocaine or heroin use while 
driving in a week.  There were no meaningful significant differences identified between the 
regions on self-reported frequency of drug driving.  Finally, examination of the self-
reported drug use for the 101 individuals who tested positive to the presence of drugs 
revealed that drug driving was most common among these individuals.   For example, a 
greater proportion reported engaging in drug driving practices in the last year compared to 
those who did not test positive (e.g., 51.5% vs 16.5%, respectively).   
 
Table 2. Drug Driving Behaviour 
Cannabis Amphetamine Cocaine Meth/MDMADrug Type n % n % n % n % 
Drug Driving 
 Every day 
 More than once week 
 About once a week 
 11 - 20 times 
 3 - 10 times 
 Once or twice 
 Never 
 
 46 
 37 
 32 
 26 
 38 
 154 
2602 
 
(1.8) 
(1.4) 
(1.2) 
(1.0) 
(1.5) 
(5.9) 
(87.2)
 
 
 4 
 9 
 15 
 25 
 20 
 55 
2484 
 
(0.2) 
(0.3) 
(0.6) 
(1.0) 
(0.8) 
(2.1) 
(95.1)
 
 0 
 0 
 2 
 8 
 8 
 38 
2554 
 
(0.0) 
(0.0) 
(0.1) 
(0.3) 
(0.3) 
(1.5) 
(97.9) 
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 7 
 8 
 11 
 23 
 74 
2487 
 
(0.1) 
(0.0) 
(0.0) 
(0.0) 
(0.0) 
(0.3) 
(99.6)
 
Discussion  
This paper aimed to report on an investigation into the incidence of drug driving in three 
Queensland regions through both self-reported data and random roadside drug testing 
technology.  A major finding of the study was that the examination of oral fluid samples 
revealed that 3.8% of the sample provided a positive illicit drug screening reading, which is 
similar to previous studies in this area (Buttress et al., 2004).   Secondly, a comparison with 
the corresponding drink driving detection rates for the associated RBT site revealed a 
greater percentage of identified drug drivers than drink drivers.  Whilst only preliminary, 
the results suggest that a greater proportion of drivers may be at risk of driving under the 
influence of drugs, rather than alcohol, in the early hours of the morning.   
 
Not surprisingly, individuals who tested positive to drugs were more likely to be young 
drivers, with lower levels of driving experience.  Importantly, while males were more likely 
to test positive for illicit substances, a sizeable proportion of females also tested positive, 
which indicates this group is also at risk of driving after consuming drugs.   
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Interestingly, a proportion of the samples that were positive contained more than one 
amphetamine type substance. One possible explanation for the detection of multiple illicit 
drugs is the manufacturing process, as recreational “party” drugs (e.g., ecstasy) are likely to 
contain more than one substance.  Examination of the self-reported data revealed that 
cannabis was the most frequently consumed illicit substance, and not surprisingly, was also 
the most frequent self-reported drug to be used when driving.  However, a greater number 
of amphetamine type substances were detected through the screening process in the current 
study.  Further research is required to determine whether this finding is a data anomaly, 
screening issue or if amphetamines, are in fact, more likely to be combined with driving in 
the late evening and early hours of the morning.  A more consistent finding was that 
individuals who tested positive to the drug testing process also reported the highest rate of 
drug driving, which provides support for the drug screening process.  Finally, there were 
few differences identified between the regions on key measures such as the number of 
positive samples or self-reported drug driving behaviours.  The results indicate that drug 
driving may prove to be a state-wide problem and that drug testing may have the capacity 
to detect a considerable proportion of drug drivers.    
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